Clicky

Sunmax Biotechnology Co Ltd(4728)

Description: Sunmax Biotechnology Co., Ltd., a biomedical company, develops, manufactures, and markets medical-grade collagen-based medical devices in Asia. The company offers Porcogen, a sterile purified collagen solution for medical device, tissue engineering, and research purposes; and dermal fillers, such as Sunmax collagen implant I-Plus and Sumax collagen implant I for the correction of facial defects, such as the fill up of wrinkles. It also provides Sunmax collagen dental bone graft, Sunmax collagen dental membrane, and Sunmax dental bone graft granules, which are used in the augmentation or reconstructive treatment of the alveolar ridge. In addition, the company offers Sunmax collagen bone graft matrix that provides a bone void filler that is resorbed and replaced with bone during the healing process; and skincare products comprising Sunmax 6 collagen facial cleanser, Sunmax 7 collagen essence, Sunmax 8 active collagen essence mask, Sunmax 9 collagen refining cream, Sunmax 10 collagen eye renewal cream, Sunmax 11 collagen moisturizing cream, Sunmax 15 Collagen MesoRepair, and Sunmax Collagen Peptide that are used as aftercare of dermal filler treatment. Sunmax Biotechnology Co., Ltd. was founded in 2001 and is based in Tainan City, Taiwan.


Keywords: Medicine Surgery Skin Skincare Products Plastic Surgery Collagen Tissue Engineering Gelatin Oral And Maxillofacial Surgery Bone Grafting Wrinkle Structural Proteins Injectable Filler

Home Page: www.sunmaxbiotech.com

No.10, Lane 31
Tainan City, 744
Taiwan
Phone: 886 6 505 3288


Exchange: TWO

Country: TW

Currency: New Taiwan Dollar (NT$)

Forward PE: 0
Trailing PE: 14.232
Price-to-Book MRQ: 7.2595
Price-to-Sales TTM: 5.8604
IPO Date:
Fiscal Year End: December
Full Time Employees: 0
Back to stocks